Cheapest tirzepatide online: real LillyDirect prices and what to avoid

The cheapest legitimate way to get tirzepatide online is from Lilly itself. LillyDirect, the company’s direct-to-patient pharmacy service, offers Zepbound vials and KwikPens to cash-paying patients for $299 to $449 a month, with a prescription. Anything cheaper is either a compounded product with legal limits or a seller the FDA warns against. Prices below were checked on Lilly’s pages on November 2, 2026.

LillyDirect self-pay prices by dose

Source: LillyDirect Zepbound page (CMAT-05333 08/2026) and Lilly’s Zepbound pricing page, both checked November 2, 2026. A month is 28 days.

Some practical details from the same pages:

• Vials are LillyDirect-only and self-pay only. They cannot be billed to insurance. Each vial holds one 0.5 mL dose, drawn with a new syringe and needle that cost extra.
• The KwikPen holds four weekly doses and needs a new pen needle each week, also extra. It is available self-pay and with some insurance.
• Delivery is free, and pickup at Walmart Pharmacy is available for vials and KwikPens.
• “Starting at” means the lowest dose. The label says 2.5 mg “is for treatment initiation and is not approved as a maintenance dosage.” The labeled maintenance doses for weight are 5, 10 and 15 mg, so the $299 tier normally lasts four weeks.
• Mounjaro is also on LillyDirect at $499 a month for any dose, self-pay. Mounjaro is approved for type 2 diabetes and related heart risk, not for weight management.

Is the cash price really the cheapest for you?

Not always, because the lowest price depends on your coverage. Lilly’s self-pay price is the floor for people paying cash, but three groups can pay less.

One trap: self-pay fills sit outside insurance, and Lilly’s savings card cannot be combined with other discounts. The tirzepatide cost guide covers list prices, card limits and Medicare in detail, and the cheapest GLP-1 without insurance guide compares other drugs.

Why is the online price lower than my pharmacy’s quote?

They are different prices for different products. A pharmacy’s cash quote for a single-dose pen tends to sit near the list price, which runs up to $1,086.37 a fill. Lilly’s direct-to-patient price is a separate price for cash-paying patients, and Lilly says the $299 applies to the KwikPen or vial, not the single-dose pen. If you were quoted about $1,000, check which device was on the prescription before assuming that is the real cost.

What does the cheapest route cost in a year?

At $449 a fill, 13 fills a year comes to about $5,837 before taxes and needles. The first year on the label’s fastest schedule is about $5,637, since the first two fills are cheaper. The figure that changes most is the refill window: at $699, a 10 mg dose reaches $9,087 over the same 13 fills. A missed refill date costs more than almost any discount saves.

How the prescription part works online

LillyDirect is a pharmacy service, not a prescriber. A licensed clinician has to send the prescription, either your own doctor or a telehealth clinician. Lilly’s pages offer links to independent telehealth and in-person care for people without a prescriber. After that, one of Lilly’s dispensing pharmacy partners contacts you to confirm the details and apply any savings.

What separates real telehealth from a storefront is the clinical review. A legitimate visit collects your medical history, current medicines and weight, checks the label’s contraindications, such as a personal or family history of medullary thyroid carcinoma or MEN 2, and ends with a clinician deciding whether to prescribe. The prescription then goes to a named, state-licensed pharmacy.

Before paying a telehealth program, ask three things in writing:

1. Will I receive Zepbound or Mounjaro itself, or a compounded product?
2. Which pharmacy dispenses it, and in which state is it licensed?
3. What is the most I could pay in any month, including membership, visit and shipping fees?

If a program uses LillyDirect, your drug price should match the table above, and any visit or membership fee is on top.

Compounded tirzepatide after the shortage

Many online programs offer compounded tirzepatide instead of Zepbound. The FDA declared the tirzepatide shortage resolved on December 19, 2024, and its grace periods ended March 5, 2025 for 503A pharmacies and March 19, 2025 for 503B outsourcing facilities. Since then, compounding has been limited to narrow cases, such as a prescriber determining a change makes a significant difference for a specific patient, like an allergy to an ingredient in the brand.

On February 6, 2026 the FDA said it would act against compounded GLP-1 products being mass-marketed as alternatives to approved drugs. It said companies cannot claim compounded products are generic versions, the same as approved drugs, or clinically proven. The compounded tirzepatide guide covers the legal test, recent enforcement, the vial label and the units math.

Red flags of an illegitimate seller

The FDA’s BeSafeRx program and its page on unapproved GLP-1 drugs list the warning signs. An online source is likely unsafe if it:

• Does not require a prescription, or skips screening by a licensed doctor.
• Sells tirzepatide “for research purposes” or “not for human consumption.” The FDA says it has warned companies selling semaglutide, tirzepatide, retatrutide, survodutide or mazdutide this way, directly to consumers with dosing instructions. These products are of unknown quality and are not legal to use on people.
• Is not licensed in the United States and by your state board of pharmacy, or has no licensed pharmacist available to answer questions.
• Claims a compounded drug is the same as Zepbound or is a generic. There is no FDA-approved generic tirzepatide.
• Offers prices that seem too good to be true. Deep discounts are on both FDA lists.
• Sends medicine that looks different from what a pharmacy dispenses, or that arrives broken, damaged, warm or without instructions. The FDA also notes that some pharmacies named on compounded labels do not exist, and that labels with spelling errors or wrong addresses are warning signs.
• Has no US physical address and phone number.

The FDA’s BeSafeRx site has a tool to look up whether an online pharmacy is licensed in your state. It takes about a minute. Suspected problems can be reported to FDA MedWatch.

What about TrumpRx?

TrumpRx.gov listed Zepbound at $299 a month when we checked on November 2, 2026, which matches the LillyDirect price for the 2.5 mg starting dose. It is not a cheaper source than Lilly’s own price.

Is a different GLP-1 cheaper than tirzepatide?

Sometimes, at the entry price. On the same day, TrumpRx listed the Wegovy pill at $149 a month and the Wegovy pen and Ozempic at $199. Those are different drugs with different results and approved uses, so the lowest sticker price is not automatically the best value. It is a fair question to raise with your prescriber.

Who should not use tirzepatide, whatever the price

The boxed warning and contraindications apply to every route. Tirzepatide must not be used by anyone with a personal or family history of medullary thyroid carcinoma or with MEN 2, or after a serious allergic reaction to it or its ingredients. The tirzepatide side effects guide has the full list.

Prices on this page were checked November 2, 2026, and Lilly can change them without notice. The page describes what each route costs; the prescriber decides whether tirzepatide is appropriate and at what dose.